Executive Summary
Across the nine filings in the India IPO Pipeline stream, the dominant theme is post-listing use-of-proceeds execution: most issuers report no deviation from stated objects, but several show material under-deployment of IPO capital, particularly in capex-heavy objects such as distillation plants and plant & machinery.
Quanto Agroworld (₹3,102.10 Cr issue, ~51% utilised, nil on the distillation plant), Harikanta Overseas (₹1,541.69 lakh unutilised, ₹0 of ₹932.50 lakh plant & machinery spent) and Anand Seamless (entire ₹2,551.68 lakh unutilised as of 30 Sep 2026) represent the clearest execution-lag cases. On the operating side, Scan Steels reported Q2 FY27 revenue of ₹17,043.87 lakh, up 28% YoY but down 34% QoQ, with headline net profit of ₹1,452.59 lakh heavily flattered by other income of roughly ₹1,195 lakh, making earnings quality the key diligence question. AhaSolar showed revenue growth of about 86% YoY to ₹6,702.94 lakh and a swing to profit, but negative operating cash flow of ₹(240.45) lakh and a sharp cash decline point to working-capital strain. Shiprocket's Company Secretary transition and Yatharth's extended utilisation deadline to 31 March 2027 are governance-related items to track. Overall, the stream reads as a set of mostly compliant but uneven post-IPO trajectories, where cash deployment pace and earnings quality matter more than headline listing metrics.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: IPO
Tracking the trend? Catch up on the prior India IPO Pipeline SEBI Regulatory Filings digest from November 04, 2026.
Investment Signals (11)
- Scan Steels ↓ (BEARISH)▲
Q2 FY27 revenue up 28% YoY to ₹17,043.87 lakh and profit swing from a ₹24.73 lakh loss to ₹1,452.59 lakh net profit, but ~₹1,195 lakh of profit came from other income, so operating earnings quality is weak
- AhaSolar Technologies ↓ (BULLISH)▲
Consolidated net sales up ~86% YoY (₹6,702.94 lakh vs ₹3,602.36 lakh) with operating profit of ₹65.19 lakh vs a loss of ₹(31.17) lakh in the prior-year half
- AhaSolar Technologies ↓ (BEARISH)▲
Operating cash flow of ₹(240.45) lakh and cash falling to ₹46.86 lakh from ₹248.34 lakh at 31 March 2026 offset the top-line gains
- Quanto Agroworld ↓ (BULLISH)▲
Farm expansion object ~56% deployed (₹853.22 Cr of ₹1,522.94 Cr), indicating the core growth capex is progressing on schedule
- Quanto Agroworld ↓ (BEARISH)▲
Distillation plant shows nil utilisation against ₹379.24 Cr allocated and general corporate purposes only ~2.2% spent (₹10.22 Cr of ₹465.00 Cr)
- Harikanta Overseas ↓ (BEARISH)▲
Working capital (₹475.00 lakh) and issue expenses (₹351.11 lakh) fully utilised, but plant & machinery at ₹0 of ₹932.50 lakh signals deployment delay on the capacity build
- Shiprocket ↓ (BULLISH)▲
₹210.00 Cr of the ₹885.50 Cr IPO proceeds fully used to repay HDFC Bank (₹133.50 Cr) and ICICI Bank (₹76.50 Cr) debt, deleveraging the balance sheet post-listing
- Symbiotec Pharmalab ↓ (BULLISH)▲
Clean first-quarter monitoring report with no deviations and ₹112.50 Cr of the ₹150 Cr issue directed to borrowing prepayment, supporting a lower debt burden
- Yatharth Hospital ↓ (BEARISH)▲
Shareholders approved extending the fund utilisation deadline to 31 March 2027 and widening the scope to all subsidiaries, which signals slower-than-planned deployment of the ₹569.71 crore proceeds
- Omnitech Engineering ↓ (BULLISH)▲
₹1,851.50 million (47.1%) of ₹4,180.00 million net proceeds utilised with no deviations, and a ₹20.96 million issue-expense surplus reallocated, showing disciplined reconciliation
- Anand Seamless ↓ (BEARISH)▲
None of the ₹2,551.68 lakh IPO proceeds were utilised as of 30 September 2026, with listing completed 29 September 2026, so deployment is entirely ahead of the company
Risk Flags (9)
- Scan Steels/Earnings Quality↓ [HIGH RISK]▼
~₹1,195 lakh of Q2 FY27 net profit (over 80% of the ₹1,452.59 lakh headline) came from other income, masking a weaker operating base
- Scan Steels/Sequential Decline↓ [HIGH RISK]▼
Revenue fell 34% QoQ from ₹25,778.84 lakh in Q1 FY27 to ₹17,043.87 lakh in Q2 FY27, indicating volatility in the revenue run-rate
- Quanto Agroworld/Use of Proceeds↓ [HIGH RISK]▼
₹1,515.29 Cr (about 49%) of the ₹3,102.10 Cr issue remains unutilised, with the distillation plant and general corporate purposes lagging materially
- Harikanta Overseas/Capex Delay↓ [MEDIUM RISK]▼
Total unutilised funds of ₹1,541.69 lakh parked in bank deposits and liquid funds, with issue expenses overrunning the original allocation by ₹21.51 lakh
- AhaSolar Technologies/Liquidity↓ [HIGH RISK]▼
Operating cash flow of ₹(240.45) lakh and short-term borrowings rising to ₹182.90 lakh from ₹86.03 lakh, with cash down to ₹46.86 lakh
- Anand Seamless/Deployment Risk↓ [MEDIUM RISK]▼
Entire ₹2,551.68 lakh IPO allocation (including ₹1,319.78 lakh for capacity expansion) remained undeployed at 30 September 2026, raising execution-timing questions
- Yatharth Hospital/Deadline Extension↓ [MEDIUM RISK]▼
Utilisation deadline pushed to 31 March 2027 following material unutilised proceeds of ₹569.71 crore, signalling project timeline slippage
- Shiprocket/Governance Transition↓ [MEDIUM RISK]▼
Company Secretary and Compliance Officer Nikhil Kumar resigned effective 5 November 2026, with successor Anil Kumar taking over from 6 November 2026, a one-day handover window
- Shiprocket/Growth Investment↓ [MEDIUM RISK]▼
No IPO funds deployed toward platform growth, marketing or technology in the quarter, so most of the ₹885.50 Cr raise is not yet funding the growth agenda
Opportunities (8)
- Quanto Agroworld/Distillation Catalyst↓ (OPPORTUNITY)◆
Once the nil-utilised distillation plant (₹379.24 Cr allocation) is commissioned, the stream's largest capex object could drive a step-change in capacity; watch the next utilisation statement
- Omnitech Engineering/Capex Pipeline↓ (OPPORTUNITY)◆
With 52.9% (₹2,080.94 million) of proceeds still unutilised and objects covering new facilities and solar installation, the remaining deployment could lift capacity in upcoming quarters
- AhaSolar Technologies/Operating Leverage↓ (OPPORTUNITY)◆
Swing from a ₹(31.17) lakh operating loss to ₹65.19 lakh operating profit on 86% revenue growth shows strong operating leverage if cash conversion improves
- Shiprocket/Deleveraging Tailwind↓ (OPPORTUNITY)◆
Repaying ₹210.00 Cr of bank borrowings with IPO proceeds lowers interest burden and improves finance-cost trajectory on the ₹885.50 Cr raise
- Symbiotec Pharmalab/Clean Compliance Record↓ (OPPORTUNITY)◆
Zero deviations and a CA-certified utilisation trail on ₹150 Cr of proceeds make it a low-governance-risk name in the stream, with ₹112.50 Cr directed to debt reduction
- Anand Seamless/Full Deployment Upside↓ (OPPORTUNITY)◆
With 100% of ₹2,551.68 lakh still to deploy, including ₹549.19 lakh for debt repayment, the company has a full capex and deleveraging runway ahead
- Harikanta Overseas/Catch-up Potential↓ (OPPORTUNITY)◆
₹932.50 lakh plant & machinery and ₹540.35 lakh factory premises allocations, currently largely unspent, could convert into capacity additions if execution accelerates
- Yatharth Hospital/Subsidiary Scope Flexibility↓ (OPPORTUNITY)◆
Widening the fund-use scope to all subsidiaries gives management room to direct proceeds to higher-return hospital assets within the group
Sector Themes (5)
- Use-of-Proceeds Execution Lag◆
Of the nine filings, at least five (Quanto, Harikanta, Anand Seamless, Yatharth, Shiprocket) show material unutilised capital at quarter/half-year end, with capex-heavy objects (plant & machinery, distillation, capacity expansion) most often behind plan, implying deployment timelines are a systemic issue in recent SME and mainboard issues
- Earnings Quality Versus Headline Growth◆
Scan Steels and AhaSolar both reported strong top-line and profit recovery, yet Scan Steels' profit was largely other income and AhaSolar's operating cash flow was negative, suggesting that headline recovery metrics should be checked against cash generation and non-operating contributions
- Debt Reduction as an IPO Use◆
Shiprocket (₹210.00 Cr) and Symbiotec (₹112.50 Cr) both directed significant proceeds to repaying bank borrowings, a pattern that deleverages balance sheets immediately and is generally viewed as lower-risk than growth capex
- Compliance Reporting Is Uniformly Clean◆
Eight of nine filings report no deviation from stated objects, with monitoring agencies (CARE, Crisil) and CA-certified statements used consistently, indicating governance is largely intact even where deployment is slow
- Working-Capital and Liquidity Pressure in Newly Listed Small Caps◆
AhaSolar's cash falling from ₹248.34 lakh to ₹46.86 lakh while borrowings rose, alongside Harikanta's large parked cash balance, shows the mix of liquidity stress and idle capital that the recently listed SME cohort is managing
Watch List (8)
-
Nil spend on ₹379.24 Cr distillation allocation and ~2.2% on general corporate purposes; watch the next utilisation statement and any reallocation of unspent funds
-
Board approved a direct listing on NSE alongside Q2 FY27 results showing ₹1,195 lakh of other income; monitor Q3 FY27 operating profit and the listing timeline
-
Negative operating cash flow of ₹(240.45) lakh and rising short-term borrowings; watch the next half-year cash flow statement for conversion of the ₹65.19 lakh operating profit
-
Extended utilisation deadline for ₹569.71 crore proceeds; watch the Q3 FY27 monitoring agency report (CARE) for progress against the new deadline
-
Company Secretary transition effective 6 November 2026 and first monitoring agency report on ₹885.50 Cr; watch subsequent utilisation and any further KMP changes
-
Entire ₹2,551.68 lakh still unutilised at 30 September 2026; the next half-year Regulation 32 filing will reveal whether capacity expansion (₹1,319.78 lakh) has started
-
₹932.50 lakh allocation with ₹0 utilised and ₹1,541.69 lakh total parked in liquid funds; watch the next BSE deviation statement for capex progress
-
52.9% of net proceeds unutilised; the Crisil-monitored next-quarter report will show whether facility capex and solar installation are accelerating
Filing Analyses
(9)
05-11-2026
Omnitech Engineering Ltd filed the Monitoring Agency Report from Crisil Ratings for the quarter ended September 30, 2026, regarding utilization of its ₹4,180.00 million IPO proceeds. As of quarter-end, ₹1,851.50 million (47.1%) of the net proceeds have been utilized, while ₹2,080.94 million (52.9%) remain unutilized. The funds are being deployed towards capital expenditure at new facilities, solar panel installation, and general corporate purposes, with no deviations from the objects stated in the offer document.
- · No deviations from the objects of the issue were observed.
- · The Audit Committee and Board of Directors approved the report on November 4, 2026.
- · During the quarter ended June 30, 2026, a reconciliation of issue expenses resulted in a downward revision from ₹366.25 million to ₹345.29 million, creating a surplus of ₹20.96 million. Of this, ₹15.03 million was reallocated to General Corporate Purposes and ₹5.93 million was refunded to Selling Shareholders.
- · The actual issue expenses attributable to Selling Shareholders were ₹97.73 million against an estimated ₹103.66 million, resulting in a refund of ₹5.93 million.
- · For Facility 1, ₹302.77 million has been utilized out of ₹1,328.44 million proposed, with ₹1,025.67 million unutilized.
- · For Facility 2, ₹236.80 million has been utilized out of ₹1,007.14 million proposed, with ₹770.34 million unutilized.
- · For solar panels/equipment at Existing Facility 2, ₹152.24 million has been utilized out of ₹186.98 million proposed, with ₹34.74 million unutilized.
- · For General Corporate Purposes, ₹659.69 million has been utilized out of ₹909.88 million revised allocation, with ₹250.19 million unutilized.
- · Issue expenses of ₹223.56 million have been paid out of ₹247.56 million, with ₹24.00 million pending crystallization.
05-11-2026
Yatharth Hospital & Trauma Care Services Limited filed a Monitoring Agency Report from CARE Ratings for the quarter ended September 30, 2026, regarding the utilization of its ₹569.71 crore IPO proceeds. The report confirms no deviation from the stated objects, but reveals that a significant portion of funds remained unutilized, leading the company to seek and receive shareholder approval at the AGM on September 25, 2026, for an extension of the utilization deadline to March 31, 2027, and a revision in the scope of fund usage to include all subsidiaries.
- · The Monitoring Agency Report was issued by CARE Ratings Limited, appointed as per the Monitoring Agency Agreement dated July 15, 2023.
- · The Audit Committee reviewed and took note of the report in its meeting held on November 03, 2026.
- · Shareholder approval for the extension of the fund utilization deadline to March 31, 2027, and revision in scope was obtained at the AGM dated September 25, 2026.
- · For Item 2 (repayment of subsidiary borrowings), no utilization was made during Q2 FY27, leaving ₹142.72 crore unutilized out of the proposed ₹145.00 crore.
- · The CA certificate from M S K A & Associates (Statutory Auditor) dated October 28, 2026, provides 'limited assurance' regarding the details mentioned therein.
- · The report declares no deviation from the objects and no material deviation requiring shareholder approval beyond what was already obtained.
05-11-2026
Harikanta Overseas Ltd filed a statement with BSE confirming no deviation or variation in the use of IPO proceeds of ₹2,429.70 lakh for the half year ended 30th September 2026. While the company has fully utilized funds for working capital (₹475.00 lakh) and issue expenses (₹351.11 lakh), it has significantly underutilized funds for factory premises capital expenditure (₹40.00 lakh utilized out of ₹540.35 lakh) and plant & machinery (₹0 utilized out of ₹932.50 lakh), with total unutilized funds of ₹1,541.69 lakh temporarily parked in bank deposits and liquid funds. Additionally, issue expenses exceeded the original allocation by ₹21.51 lakh, which was adjusted against the general corporate purposes allocation.
- · The IPO was a book-building issue under SEBI ICDR Regulations, 2018.
- · Equity shares were listed on BSE SME platform on 2nd June 2026.
- · The Audit Committee and Board reviewed the deviation statement on 5th November 2026.
- · No monitoring agency was appointed for the IPO proceeds.
- · Unutilized funds are temporarily parked in bank accounts, fixed deposits, liquid funds, and mutual funds.
05-11-2026
Quanto Agroworld Limited submitted a statement to the NSE on 04-11-2026 on utilisation of its IPO proceeds, as of 30 September 2026, with an independent chartered accountant's utilisation certificate attached. Of total issue proceeds of ₹3102.10 Crore (per the Prospectus dated 08 September 2026), ₹1586.81 Crore (about 51%) has been utilised and ₹1515.29 Crore remains unutilised. Utilisation is well behind plan for the distillation plant (nil spent against ₹379.24 Crore) and for general corporate purposes (₹10.22 Crore spent against ₹465.00 Crore), while the farm expansion and debt prepayment objects are largely deployed.
- · Distillation plant capex (₹379.24 Crore allocated) shows zero utilisation as of 30-09-2026
- · General corporate purposes (₹465.00 Crore allocated) shows only ₹10.22 Crore utilised, about 2.2%
- · Farm expansion utilised ₹853.22 Crore of ₹1522.94 Crore allocated, about 56%
- · Unutilised amounts are stated exclusive of GST; the statement cites the Prospectus dated 08 September 2026
- · The utilisation certificate was issued under SEBI and BSE fund-utilisation requirements, with the auditor providing reasonable assurance on the books of account
05-11-2026
AHASOLAR TECHNOLOGIES LIMITED reported consolidated net sales of Rs. 6,702.94 Lakhs for the half year ended September 30, 2026, versus Rs. 3,602.36 Lakhs in the half year ended September 30, 2025, an increase of roughly 86%. Net profit rose to Rs. 47.19 Lakhs from a loss of Rs. 11.53 Lakhs in the prior-year half, while the company's Rs. 308.23 Lakh paid-up equity capital was unchanged. Cash and cash equivalents declined sharply to Rs. 46.86 Lakhs from Rs. 248.34 Lakhs at March 31, 2026, and operating cash flow was negative at Rs. (240.45) Lakhs.
- · Operating profit before other income, finance costs and exceptional items was Rs. 65.19 Lakhs versus a loss of Rs. (31.17) Lakhs in the prior-year half
- · Total borrowings (short-term) rose to Rs. 182.90 Lakhs from Rs. 86.03 Lakhs at March 31, 2026
- · Property, plant and equipment rose to Rs. 710.92 Lakhs from Rs. 60.08 Lakhs, while Capital Work in Progress fell to Rs. 7.12 Lakhs from Rs. 690.45 Lakhs, indicating capitalization of prior-period capex
- · Employee benefits expense rose 17.6% year-on-year to Rs. 317.01 Lakhs, and purchase of stock in trade rose 91.3% to Rs. 6,106.63 Lakhs, reflecting thinner margins on the revenue growth
- · Inventories increased to Rs. 126.04 Lakhs from Rs. 22.63 Lakhs and trade receivables increased to Rs. 561.12 Lakhs from Rs. 380.52 Lakhs, tying up working capital
- · Subsidiary RTC Energy Private Limited's financials were not reviewed by the statutory auditor, though the auditor stated its opinion is not modified
- · Cash flow statement and balance sheet cash figures differ (Rs. 41.44 Lakhs vs Rs. 46.86 Lakhs), with the difference attributed to fixed deposits maturing beyond 3 months
05-11-2026
Scan Steels Limited's board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, and approved a direct listing of its existing equity shares on NSE. Q2 FY27 revenue from operations was ₹17043.87 Lacs, down 34% from Q1 FY27 (₹25778.84 Lacs) but up 28% YoY from ₹13295.69 Lacs; net profit was ₹1452.59 Lacs versus a loss of ₹24.73 Lacs in the year-ago quarter, though approximately ₹1196.16 Lacs of the quarter's profit came from other income.
- · Q2 FY27 profit was heavily supported by other income of ₹1194.80 Lacs, versus ₹6.29 Lacs a year earlier; operating profit quality is weaker than the headline net profit suggests
- · Q2 FY27 total expenses rose 22.2% YoY to ₹16298.70 Lacs, outpacing the 28.2% revenue growth only modestly, with finance costs up to ₹242.15 Lacs from ₹216.84 Lacs
- · Q2 FY26 posted a net loss of ₹24.73 Lacs, so the YoY swing to profit is driven by the sharp revenue recovery and the large other income contribution
- · Inventories rose to ₹17302.19 Lacs from ₹16811.80 Lacs and trade receivables increased 53.5% to ₹3239.07 Lacs since March 2026, signalling working capital build-up
- · Net cash from operating activities was only ₹431.68 Lacs in H1 FY27, versus an outflow of ₹2155.92 Lacs in H1 FY26; the improvement is partly offset by heavy capex of ₹1925.43 Lacs
- · Borrowings increased materially: non-current borrowings of ₹2083.04 Lacs were newly raised, and short-term borrowings rose to ₹7868.46 Lacs
- · Paid-up equity share capital increased to ₹6074.65 Lacs from ₹5860.23 Lacs, and instruments entirely equity in nature (₹204.21 Lacs) were eliminated
- · Board meeting commenced at 4:00 PM and concluded at 5:40 PM on November 5, 2026; statutory auditors issued a Limited Review Report on the results
- · Financial results to be published in newspapers under Regulation 47 of SEBI Listing Regulations; results also available on the company website and BSE website
05-11-2026
Anand Seamless Limited has filed its Regulation 32 statement confirming no deviation or variation in the utilization of IPO proceeds for the half year ended September 30, 2026. The company raised Rs. 2551.68 Lakhs through its Initial Public Offer, which was allotted on September 25, 2026 and listed on September 29, 2026. The statutory auditor, Chirag R. Shah & Associates, has certified the utilization position.
- · Total IPO allocation of Rs. 2551.68 Lakhs comprises Rs. 1319.78 Lakhs for capacity expansion and operations, Rs. 549.19 Lakhs for debt repayment, Rs. 312.72 Lakhs for issue expenses and Rs. 369.99 Lakhs for general corporate purposes
- · As of September 30, 2026, none of the allocated IPO amounts were utilised, so the entire Rs. 2551.68 Lakhs remains unutilised
- · Monitoring agency is not applicable for this issue
- · Auditor's certificate notes that out of the total amount, Rs. 2.304 Lakhs was received on a date partially illegible in the source document
- · The company's registered office and plant are located at Ankhol Patiya, Chhatral-Kadi Road, Mehsana, Gujarat, and the company holds ISO 9001, ISO 14001 and ISO 45001 certifications
05-11-2026
Symbiotec Pharmalab Ltd filed a Monitoring Agency Report from CARE Ratings for the quarter ended September 30, 2026, covering utilisation of its IPO proceeds aggregating Rs.150 crore. The report states there were no deviations from the stated objects of the issue and no deviation range applies. The filing is a routine regulatory compliance disclosure with no adverse findings.
- · Proceeds allocation: Rs.112.50 Cr for prepayment/repayment of borrowings, Rs.29.53 Cr for general corporate purposes, and Rs.7.98 Cr for offer-related expenses; no cost revisions reported.
- · Monitoring Agency Agreement dated August 06, 2026; CA certificate from Mahesh C Solanki & Co. (peer-reviewed audit firm) dated November 2, 2026, served as the source of utilisation information.
- · Management certified there is no other relevant information that may materially affect investor decision-making.
05-11-2026
Shiprocket Ltd's board approved unaudited financial results for Q2 FY27 and noted the first monitoring agency report for its ₹885.50 Cr IPO proceeds. The company fully utilized ₹210.00 Cr of IPO funds to repay borrowings (₹133.50 Cr to HDFC Bank and ₹76.50 Cr to ICICI Bank), but no funds were deployed toward platform growth, marketing, or technology initiatives during the quarter. Additionally, Company Secretary Nikhil Kumar resigned effective November 5, 2026, and Anil Kumar was appointed as his successor effective November 6, 2026.
- · The board meeting commenced at 10:20 AM IST and concluded at 11:17 AM IST on November 5, 2026.
- · Nikhil Kumar's resignation as Company Secretary and Compliance Officer was effective from close of business on November 5, 2026.
- · Anil Kumar's appointment as Company Secretary and Compliance Officer (KMP) is effective from November 6, 2026.
- · No deviation from the objects of the IPO was reported by the monitoring agency.
- · The monitoring agency confirmed no change in means of finance and no major deviation from earlier reports (this being the initial report).
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 9 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India IPO Pipeline SEBI Regulatory Filings
November 03, 2026
India IPO Pipeline SEBI Regulatory Filings — November 03, 2026
November 02, 2026
India IPO Pipeline SEBI Regulatory Filings — November 02, 2026
October 31, 2026
India IPO Pipeline SEBI Regulatory Filings — October 31, 2026
October 30, 2026
India IPO Pipeline SEBI Regulatory Filings — October 30, 2026
🇮🇳 More from India
View all →November 06, 2026
India Pre-Market Regulatory Roundup — November 06, 2026
India Pre-Market Regulatory Roundup
November 06, 2026
India Quarterly Results BSE NSE Announcements — November 06, 2026
India Quarterly Results BSE NSE Announcements
November 06, 2026
India Upcoming Corporate Actions BSE NSE — November 06, 2026
India Upcoming Corporate Actions BSE NSE
November 06, 2026
India RBI Monetary Policy Repo Rate Decisions — November 06, 2026
India RBI Monetary Policy Repo Rate Decisions